Pelthos Therapeutics PTHS
NYSE PTHS
$9.45 +0.55 (+6.35%)
As of: Nov 11, 2026 · 1:56 PM EST

Pelthos Therapeutics (PTHS) Price to Book (2024 - 2026)

Updated

Pelthos Therapeutics' Price to Book came in at 3.67 for Q1 2026, up 145.1% from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Price to Book (2024 - 2026) Analysis & Trends

For FY2025, Pelthos Therapeutics' Price to Book was 1.50.

  • The Q1 2026 figure represents the highest quarterly Price to Book since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Pelthos Therapeutics 33.36 Mn -55.04 Mn 11.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 3.67
Dec 31, 2025 1.50
Sep 30, 2025 1.49
Mar 31, 2024 10.88
API Access

Pelthos Therapeutics Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=PTHS&period=max&api_key=YOUR_API_KEY